Agilent Technologies (A) to Acquire BIOVECTRA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Jefferies Reiterates Hold Rating on Agilent (A)
July 22, 2024 12:42 PM EDTJefferies analyst Brandon Couillard reiterated a Hold rating and $135.00 price target on Agilent (NYSE: A).
The analyst comments "Agilent's move to acquire BIOVECTRA ($925M, or ~7x '24 revenues) would expand exposure to specialized CDMO market, adding PDNA, mRNA and HPAPI capabilities to... More
